NEW YORK, Sept. 11, 2019 /PRNewswire/ --
Market Overview
The Asia Pacific apheresis market
studied is anticipated to grow with an CAGR of 11.26%, during the
forecast period (2019-2024).
Read the full report:
https://www.reportlinker.com/p05815097/?utm_source=PRN
The major factors attributing to the growth of the Asia Pacific apheresis market are increasing
diseases burden, rise in demand for blood components and associated
safety and technological advancement in the development of new
apheresis techniques. However, the factors such as high capital
investment and cost associated with apheresis procedures is
expected to restrain the market.
Apheresis has now become a popular mode of treatment for multiple
complex immune disorders and there has been a remarkable change in
the scenario pertaining to therapeutic apheresis in Asia-Pacific. With the increasing number of
diseases and accident cases, along with technological advancements,
the market studied is expected to experience a boost during the
forecast period. Additionally, the rising number of government
initiatives, blood donation camps, and increasing awareness about
healthcare are the factors responsible for the growth of the market
studied. Apheresis technology is expensive. It is also technically
and medically demanding.
Scope of the Report
Apheresis is a medical technique, where the blood of an individual,
either a donor or patient, is passed through an apparatus that
separates a particular constituent and returns the rest of the
blood to the circulatory system. This is an extracorporeal
therapy.
Key Market Trends
Neurological Disorders is Expected to Grow with High CAGR in the
Indication Segment
The pattern of neurologic diseases in Asia is largely similar to that in the western
countries, with cerebrovascular diseases, headache, and epileptic
seizures being the most common complaints.
Disease features that are specific to Asia include a high proportion of strokes
among the youth, mostly from premature atherosclerosis, a high
prevalence of intracranial vs extracranial diseases, the relative
commonality of neuromyelitis optica and the optic-spinal form of
multiple sclerosis (MS), and high incidences of sex-linked dystonia
and Parkinson's disease. Plasma exchange is one of the
well-established therapeutic procedures that is usually used in
many neurological autoimmune disorders. It is thought that the
effects of plasma exchange occur through the elimination of
pathognomonic inflammatory mediators, including autoantibodies,
complement components, and cytokines. Most of the neurological
disease treatments are benefited with therapeutic apheresis, and
these effects most likely occur through the removal of harmful
pathogenic autoantibodies and associated inflammatory
mediators.
Competitive Landscape
The Asia Pacific aphersis market
is moderately competitive and consists of several major players. In
terms of market share, few major players are currently dominate the
apheresis market. With the increasing prevalence of diseases in the
Asia pacific region and the usage
of apheresis is expected to rise, thereby few other players are
also expected into the market. Some of the major players of the
market are Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus
Corporation, Kaneka Corporation and Terumo Corporation are among
others.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client's requirements
- 3 months of analyst support
Read the full report:
https://www.reportlinker.com/p05815097/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution.
Reportlinker finds and organizes the latest industry data so you
get all the market research you need - instantly, in one place.
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
View original
content:http://www.prnewswire.com/news-releases/the-asia-pacific-apheresis-market-studied-is-anticipated-to-grow-with-an-cagr-of-11-26-during-the-forecast-period-2019--300916019.html
SOURCE Reportlinker